Enzymes conjugated to antiobodies via a PEG heterobifuctional linker

Details for Australian Patent Application No. 2006239315 (hide)

Owner Ventana Medical Systems, Inc.

Inventors Lefever, Mark; Ashworth-Sharpe, Julia; Wong, Jennifer; Bieniarz, Christopher; Kernag, Casey A.; Kosmeder, Jerome W.

Agent Pizzeys

Pub. Number AU-B-2006239315

PCT Pub. Number WO2006/116628

Priority 60/675,759 28.04.05 US

Filing date 27 April 2006

Wipo publication date 2 November 2006

Acceptance publication date 1 March 2012

International Classifications

C07K 19/00 (2006.01) Hybrid peptides

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Event Publications

8 November 2007 PCT application entered the National Phase

  PCT publication WO2006/116628 Priority application(s): WO2006/116628

1 March 2012 Application Accepted

  Published as AU-B-2006239315

28 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006239318-Cancer specific PCNA isoform binding antibodies and uses thereof

2006239313-Methods and compositions for treating pain